CIK 0001672619
- Non-accelerated filer
Enliven Therapeutics, Inc.
Sign in to watch- Ticker
- ELVN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 811523849
- Phone
- +1 650-547-5814
- Business address
- 205 PARK ROAD, BURLINGAME, CA, 94010
- Former names
- IMARA Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,819,567
- in 6 filings, $1.2M under 10b5-1 plans
Net −$1,819,567. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-06-02 | MOTT DAVID M Director | Grant or award · Stock Options (Right to Buy) | +8,500 | 8,500 | ||
| 2022-02-23 | MOTT DAVID M Director | Purchase | +35,257 | $1.46 | $51K | 229,224 |
| 2022-02-22 | MOTT DAVID M Director | Purchase | +65,817 | $1.56 | $103K | 193,967 |
| 2022-02-18 | MOTT DAVID M Director | Purchase | +50,398 | $1.30 | $66K | 128,150 |
| 2022-02-17 | MOTT DAVID M Director | Purchase | +14,595 | $1.17 | $17K | 77,752 |
| 2022-02-16 | MOTT DAVID M Director | Purchase | +11,779 | $1.20 | $14K | 63,157 |
| 2022-02-15 | MOTT DAVID M Director | Purchase | +19,552 | $1.20 | $23K | 51,378 |
| 2022-02-14 | MOTT DAVID M Director | Purchase | +8,500 | $1.18 | $10K | 31,826 |
| 2022-02-11 | MOTT DAVID M Director | Purchase | +14,573 | $1.23 | $18K | 23,326 |
| 2022-02-10 | MOTT DAVID M Director | Purchase | +8,753 | $1.29 | $11K | 8,753 |
| 2021-06-29 | MOTT DAVID M Director | Grant or award · Stock Option (right to buy) | +7,728 | 7,728 | ||
| 2020-03-16 | MOTT DAVID M Director | Grant or award · Stock Option (right to buy) | +15,457 | 15,457 |
Page 1 of 1 · 12 trades